In the presence of retinal hemorrhage, SRF, or IRF, nAMD almost always requires treatment with intravitreal injection of anti-vascular endothelial growth factor (Anti-VEGF) [2]. The gene discussed is VEGFA; the disease is Retinal hemorrhage.